Medtronic PLC
MDT Healthcare Medical Devices
Medtronic PLC’s revenue for fiscal 2026 (year ended April 2026) was $36.4 billion, up 8.43% from fiscal 2025.
- Revenue
- +13.7%
- EPS
- +42.0%
- Free cash flow
- +120.9%
- Total debt
- −1.59%
Quarter to July 2026, against a year earlier
Follow MDT
Alert me
Medtronic PLC (MDT) Net income
Medtronic PLC's net income for fiscal 2026 was $4.8B, unchanged from fiscal 2025. Over the twelve months to 31 July 2026 it was $5.3B. Over the past ten years it has ranged from $2.7B (fiscal 2015) to $5.1B (fiscal 2022); the current reading is higher than 92% of that period. Medtronic PLC ranks 2nd of 149 Medical Devices companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2026 | $4.8B | 3.11% |
| FY2025 | $4.7B | 26.61% |
| FY2024 | $3.7B | (2.09%) |
| FY2023 | $3.8B | (25.25%) |
| FY2022 | $5.1B | 39.45% |
| FY2021 | $3.6B | (24.47%) |
| FY2020 | $4.8B | 3.35% |
| FY2019 | $4.7B | 50.24% |
| FY2018 | $3.1B | (23.09%) |
| FY2017 | $4.0B | 13.74% |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Jul 2026 | $1.5B | 17.47% |
| Apr 2026 | $1.3B | 9.48% |
| Jan 2026 | $1.2B | (16.73%) |
| Oct 2025 | $1.4B | 31.90% |
| 43 more quarters | Free account |
Against its own ten years
Net income against peers
| Company | Net income |
|---|---|
| ABT Abbott Laboratories compare | $5.4B |
| MDT Medtronic PLC | $5.3B |
| SYK Stryker Corporation compare | $3.6B |
| BSX Boston Scientific Corporation compare | $3.5B |
| GEHC GE HealthCare Technologies Inc. compare | $2.2B |
| PHG Koninklijke Philips N.V. compare | $1.1B |
| EW Edwards Lifesciences Corporation compare | $1.0B |
| DXCM DexCom, Inc. compare | $991.0M |
| STE STERIS plc compare | $829.8M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on MDT
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement